Log In or Register to Join The Conversation!

Control Group for EGCG + IPF Longitudinal Survey

Viewing 2 reply threads
  • Author
    Posts
    • #24985

      Hi Everyone,

      As you know, there has been a lot of discussion on the forums regarding the EGCG Green Tea extract and pulmonary fibrosis. This topic originated after a New England Journal of Medicine (NEJM) study was published on EGCG earlier this year, which was called Reversal of TGβ1-Driven Profibrotic State in Patients with Pulmonary Fibrosis. 

      While BioNews Insights (the research division of BioNews Services) does not have the capability to formally conduct any type of clinical trial using EGCG, we are excited about the information we’re looking to obtain via a longitudinal questionnaire. Thank you to everyone who has offered to lend your voice to this project! 

      We’re nearly finished the questionnaire to help us collate everyone’s experience with EGCG and IPF/PF, then we’ll be able to pull together some interesting information in an easy-to-read graphic. This was built based on feedback from the primary investigator (PI) of the NEJM study who is a physician out of UCSF. We spoke to him recently, and another piece of feedback he had was to establish a control group for this project.

       

      If you are not on Ofev, Esbriet OR taking EGCG: would you be willing to participate in this longitudinal questionnaire, as part of a control group, to help us propel this project forward?

      If so, or if you’d like more information, please email me at: [email protected]

       

      Many thanks in advance to everyone already participating and for those considering.

      Sincerely,
      Charlene + BioNews Insights team.

    • #25010
      Steve Dragoo
      Participant

      @charlene-marshall

      I would but I started ab OTC EGCG a few weeks ago…

    • #25019

      No problem @steve-dragoo , thanks for letting my know my friend!
      Sincerely,
      Char.

Viewing 2 reply threads
  • You must be logged in to reply to this topic.
Copyright © 2017-2020 All rights reserved.

©2020 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account